Treatment of Clostridium difficile disease in patients not responding to metronidazole.
Kapoor
Shailendra
S
D000617:Aminoglycosides / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000187:drug effects*; D003015:Clostridium Infections / Q000188:drug therapy* / Q000382:microbiology / Q000628:therapy; D003967:Diarrhea / Q000188:drug therapy / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D000077732:Fidaxomicin; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008795:Metronidazole / Q000627:therapeutic use*; D011108:Polymers / Q000627:therapeutic use; D013451:Sulfonic Acids; D017211:Treatment Failure; D016896:Treatment Outcome
D000617:Aminoglycosides; D000890:Anti-Infective Agents; D016756:Immunoglobulins, Intravenous; D011108:Polymers; D013451:Sulfonic Acids; D008795:Metronidazole; D000077732:Fidaxomicin; C077114:styrenesulfonic acid polymer